Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth

NCT00659022 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms
Liver Neoplasms

Interventions

PROCEDURE: immediate surgery (resection of primary colorectal tumor)
DRUG: neo-adjuvant treatment with bevacizumab
DRUG: neoadjuvant treatment with capecitabine and oxaliplatin
DRUG: neo-adjuvant treatment with bevacizumab, capecitabine and oxaliplatin

Sponsor

Radboud University Medical Center